Please assess the completion status of the following clinical trial:

Trial Title: Minor Traumatic Brain Injury : MRI Examination of Consequences and Social Insertion

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who answered to psychological questionnaires 3 month after mTBI~* Patients with mTBI according to European Federation of Neurological Societies~* Initial CT scan indication according to 2012 French Society of Emergency Medicine and European Federation of Neurological Societies~* Health insurance~* Written consent~Exclusion Criteria:~* Under 18 years~* Psychiatric or neurologic history with long term treatment~* Hospitalization due to extra-cranial wounds or intoxication (except alcool)~* MTBI due to aggression~* MRI contraindication~* Inability to understand french language~* Pregnant or breastfeeding women~* Incapacitated patients in accordance with article L 1121-5 to L1121-8 of the public health code~* Patients in another study's exclusion time~* Inability to have a follow-up~* Patients who can't be reached in case of emergency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Symptomatic group at three month (Type: EXPERIMENTAL): Rivermead Post-Concussion Syndrome \>= 12 MRI and clinical exam and sociological interview at day 105 (+/-15 days) 6 months follow up : sociological interview~1 year follow up : psychological and sociological interview, Rivermead Post Concussion Syndrome questionnaire
- Asymptomatic group at three month (Type: EXPERIMENTAL): Rivermead Post-Concussion Syndrome \< 12 MRI and clinical exam and sociological interview at day 105 (+/-15 days) 6 months follow up : sociological interview~1 year follow up : psychological and sociological interview, Rivermead Post Concussion Syndrome questionnaire

Based on this trial design, predict the completion outcome and termination type (if applicable).